Literature DB >> 27152307

The Relevance of Women's Diseases, Jun Activation-domain Binding Protein 1 (JAB1) and p27(kip1).

Mijin Kim1, Tae-Hee Kim2, Hae-Hyeog Lee2.   

Abstract

The Jun activation-domain binding protein 1 (Jab1) recognize a potential coactivator of activator protein 1 (AP-1) such as c-fos, c-jun transcription factor and the fifth subunit of the COP9 signalosome complex. Also, Jab1 activate the c-jun gene resulted cell proliferation. Not only a powerful tumor suppressor but also regulator of apoptosis negative cdk inhibitor p27(kip1) are involved in the cell cycle. This is Jab1 and p27(kip1) interact with each other, Jab1 accelerate p27(kip1) from nuclear to cytoplasm through ubiquitin/proteasome pathway. However, information about the relationship between Jab1 and p27(kip1) is not known much. Taken together, the results of this study identify function and structure of Jab1 and p27(kip1) were described in a recent article on the basis of relevant. Besides Jab1 and p27(kip1) will organize the relationship between the disease and women.

Entities:  

Keywords:  Breast neoplasms; Cyclin-dependent kinase inhibitor p27; Endometriosis; Ovarian neoplasms

Year:  2016        PMID: 27152307      PMCID: PMC4854662          DOI: 10.6118/jmm.2016.22.1.6

Source DB:  PubMed          Journal:  J Menopausal Med        ISSN: 2288-6478


Introduction

The Jun activation-domain binding protein 1 (Jab1) is initially identified as a coactivator of activator protein (AP-1) transcription factor and found a component of the COP9 signalosome (CSN) complex, contained modulating signal transduction, gene transcription, and protein stability.12 Jab1 interacted with p27kip1 and translocate it's from nuclear to cytoplasm which resulted in acceleration of p27kip1 degradation through the ubiquitin-dependent/proteasome pathway and promotes cell-cycle progression.3 p27kip1 is an inhibitor of cyclin-dependent kinases (CDKs), performing potential tumor suppressor gene in diversity of human's cancer. CDK is a family of protein kinases, the activity of the serine/threonine kinases known as cdk that are under the strict control of positive and negative regulators. Until now studies have found that p27kip1 promotes apoptosis, growth inhibition and cell cycle arrest.45 Reduction of p27kip1 protein means high resistance and poor prognosis to anticancer drug. Down regulation of p27kip1 protein is often discovered by human cancers including breast and ovarian cancer and is normally correlated with poor clinical outcome. As a result, the concentration of the p27kip1 protein can be expressed as an important marker in the development of human cancer. Accordingly, this study examines a correlation of p27kip1 and Jab1, will reveal the relevant disease in women.

Jab1, p27Kip1 Structure and Function

Jab1 has been involved to the tumorigenic process, therefore, jab1 have the potential to be an effective beneficial target that affect the interaction of many tumor stage. Size of Jab1 is an -40 kDa soluble protein, also Jab1 is located on chromosome 8. Jab1 interacted with p27kip1 and improved its cytoplasmic translocation which resulted in acceleration of p27kip1 degradation through the ubiquitin and proteasome pathway. It is well known that p27kip1 protein levels are mainly regulated through degradation by ubiquitin-dependent proteolysis. Control of p27kip1 and Jab1 is important process in cancer progression, which is controlled by both the positive and negative regulators. p27kip1 is a kind of cdk inhibitors, suppresses the G1-to-S cell cycle progression, functions as a main negative regulator of apoptosis and is, thus, considered a tumor suppressor.6 The main function of this p27kip1 is to inhibit the CDK2-cyclin E complex by controlling at the G1 to S tarnsition in normal cells.

Jab1, p27kip1 and Breast Cancer

Jab1 is an important protein in breast cancer progression comes from the recent study that it is a downstream target for HER2-2/neu.7 Amplification and overexpression of HER-2/neu was established in many cancers and upregulating of this oncogene was associated with increased metastasis and prognosis. Especially, HER-2/neu oncogene (known for erbB2) is a critical biomarker, target of therapy for roughly 30% of breast cancer patients and expression of HER-2/neu is upregulated in the existence of tamoxifen, leading to tamoxifen resistance in breast cancer. The role of Jab1 interacts with c-myc gene in breast cancer cells.8 C-myc is regulator gene, including apoptosis, transformation, metabolism and cell cycle progression. On the other hand, the lower level of p27 in breast tumors was high grade. Estrogen receptor-negative and progesterone receptor-positive p27 showed a positive correlation between low levels in breast cancer.

P27kip1 and Endometriosis

Endometriosis is the endometrial tissue in the uterus that should be present in the abdominal cavity outside the uterus,9 a common disease that occurs in approximately 10 to 15% woman of childbearing age. The cause of endometriosis, though not known as yet, regurgitation of menstrual blood, immunological factors, genetic factors and family history factors have been established occurrence of endometriosis. According to previous research compared to the healthy women were reported for endometriosis and endometriosis in infertile women, following studies have been reported to demonstrate the changes in the endometrium of women with disease.1011 Moreover the before-mentioned transformation demanded the establishment of the endometrium in the peritoneal, recent evidence indicated that uterine mucosal cells of patients with endometriosis do not follow the normal growth pattern and apoptosis.121314 In the midst of CDK inhibitors, we should be focused on p27kip1. The critical function of p27kip1 is to inhibit CDK-cyclin E complex by controlling a checkpoint in the G1 in normal cells. When p27kip1 is not present in the cells, cells are not follow a cell cycle control signal and proliferation.15 Because endometrial cell cycle changes may be involved in cell cycle regulation of endometriosis in women with diseases significance of p27kip1 protein level it can be seen that a change in the lining of a particular cell cycle is important.

Jab1, p27 and Ovarian Cancer

Ovarian cancer is malignant tumor, the most widely occurring between 50 to 70 years old woman.1617 The second most common cause of gynecologic cancer in succession cervical cancer has been identified as a family history, a lot of ovulation number. No proven method for ovarian cancer is often rapidly progressive and fatal disease early symptoms rarely.5 As a negative regulator of the cell cycle, p27kip1 is tumor suppressor,6 which inhibits cyclin-CDK in a dosage dependent manner to control cell cycle progression.78 Recently, decreased expression of p27kip1 has been frequently detected in human cancers,5101112131415 including ovarian carcinoma. Recently, the expression of Jab1 and p27kip1 in a malignant epithelial ovarian cancer, was found to be correlated with the reverse p27kip1 expression levels as a result Jab1 negative regulator.18 That is a negative regulator of p27kip1 Jab1 has been associated with the development of the ovarian tumor, progression and prognosis.

Summary

Jab1 is a protein that enhances the activity of the c-jun gene and induce cell proliferation, p27kip1 is a strong reduction in the tumor suppressor gene p27kip1 has a high resistance and poor prognosis in cancer. Also p27kip1 has an important role cell cycle regulatory factors. Recently, Jab1 and p27kip1 has been reported that many women involved in diseases such as breast cancer, endometriosis and ovarian cancer. As well as Jab1 and p27kip1 started to reveal that the association became known widely in hepatocellular carcinoma, laryngeal carcinoma and nerves. In conclusion, a wide range of research on Jab1 and p27kip1 is expected to play a major role in reproductive system, kidney, blood vessel tissues and nerves system further physiological pathophysiological.
  18 in total

1.  Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis.

Authors:  W P Dmowski; J Ding; J Shen; N Rana; B B Fernandez; D P Braun
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 2.  COP9 signalosome revisited: a novel mediator of protein degradation.

Authors:  C Schwechheimer; X W Deng
Journal:  Trends Cell Biol       Date:  2001-10       Impact factor: 20.808

Review 3.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

4.  Expression of p27 and Jun activation domain-binding protein 1 in endometriosis.

Authors:  Tae-Hee Kim; Hae-Hyeog Lee; Soo-Ho Chung; Junsik Park; Arum Lee
Journal:  Arch Gynecol Obstet       Date:  2015-02-10       Impact factor: 2.344

5.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

6.  Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors.

Authors:  W S Lee; E S Park; D H Kim; T H Kim; H H Lee; S H Chung
Journal:  Eur J Gynaecol Oncol       Date:  2012       Impact factor: 0.196

7.  Structural and ultrastructural defects in preovulatory endometrium of normo-ovulating infertile women with minimal or mild endometriosis.

Authors:  L Fedele; M Marchini; S Bianchi; M Dorta; L Arcaini; P E Fontana
Journal:  Fertil Steril       Date:  1990-06       Impact factor: 7.329

8.  Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis.

Authors:  H M Gebel; D P Braun; A Tambur; D Frame; N Rana; W P Dmowski
Journal:  Fertil Steril       Date:  1998-06       Impact factor: 7.329

Review 9.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

10.  Genetic regulators of large-scale transcriptional signatures in cancer.

Authors:  Adam S Adler; Meihong Lin; Hugo Horlings; Dimitry S A Nuyten; Marc J van de Vijver; Howard Y Chang
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

View more
  2 in total

1.  A Case of Granular Cell Tumor of the Clitoris in a Postmenopausal Woman.

Authors:  Ji-Won Min; Yun-Sook Kim
Journal:  J Menopausal Med       Date:  2017-08-31

2.  Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.

Authors:  Qiaozhen Wang; Huancai Liu; Qing Wang; Fenghua Zhou; Yongxin Liu; Yawen Zhang; Haoyu Ding; Meng Yuan; Fengjie Li; Yanchun Chen
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.